SynthesisMedicine2021

Efficacy and safety of Lianhuaqingwen for mild or moderate coronavirus disease 2019: A meta-analysis of randomized controlled trials.

Zheng Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.